SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009371
Filing Date
2023-05-11
Accepted
2023-05-11 16:05:33
Documents
52
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 927795
2 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 13475
3 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 13411
4 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 9687
  Complete submission text file 0001558370-23-009371.txt   4063866

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20230331.xsd EX-101.SCH 27901
6 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 33503
7 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 100692
8 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 290689
9 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 202314
46 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 644973
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 23910895
SIC: 2834 Pharmaceutical Preparations